Latest News & Features
Europe
The EU’s Community Plants Variety Office has issued an information notice advising that owners of EU Community plant variety rights issued after January 29, 2019 will need to re-apply for equivalent UK rights in the event of a no-deal Brexit. 20 February 2019
Generics
Teva Pharmaceutical and the US Federal Trade Commission have reached a settlement to end their long-running battles over so called “pay-for-delay” agreements in the pharmaceutical industry. 20 February 2019
Americas
The US Food and Drug Administration has published new draft guidance on a pathway intended to boost the development of generics and lower drug prices. 19 February 2019
Big Pharma
While the final text of the European Council’s agreement on a supplementary protection certificate manufacturing waiver has yet to be released, the reported stockpiling provision has attracted criticism. 19 February 2019
Europe
The Court of Justice of the European Union has issued a judgment in favour of Warner-Lambert amid a dispute between the American pharmaceutical company and an administrative body in the Netherlands. 18 February 2019
Americas
Johnson & Johnson has announced plans to strengthen its robotics programme with the addition of Silicon Valley-based Auris Health to its business. 18 February 2019
Generics
The European Council has reached a political agreement on a proposal for the supplementary protection certificate manufacturing waiver for patent-protected pharmaceuticals. 15 February 2019
Big Pharma
Bayer suffered defeat at the hands of the EU General Court today, with the rejection of its attempt to register what the court deemed to be heart-related trademark. 14 February 2019
Europe
The development of precision treatments must be complemented by the development of precision diagnostics, as Daniel Lim of Kirkland & Ellis explains. 14 February 2019
Asia
Israel-based Teva has predicted 2019 will be a tough year, with lower revenue and profit, as the company faces generic competition for two of its top-selling drugs. 14 February 2019